Atogepant, the first oral preventive treatment for chronic migraine

Kristian A Haanes*, Lars Edvinsson

*Corresponding author for this work
1 Citation (Scopus)
Original languageEnglish
JournalLancet
Volume402
Issue number10404
Pages (from-to)748-749
Number of pages2
ISSN0140-6736
DOIs
Publication statusPublished - 2 Sept 2023

Keywords

  • Administration, Oral
  • Calcitonin Gene-Related Peptide
  • Humans
  • Migraine Disorders/drug therapy
  • Piperidines/therapeutic use

Cite this